Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia

被引:18
作者
Amarnani, Raj [1 ]
Travis, Simon [2 ]
Javaid, Muhammad Kassim [1 ]
机构
[1] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England
[2] Oxford Univ Hosp NHS Fdn Trust, NIHR Oxford Biomed Res Ctr, Translat Gastroenterol Unit, Oxford, England
关键词
D O I
10.1093/rheumatology/kez627
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2166 / 2168
页数:4
相关论文
共 7 条
  • [1] Non-renal-Related Mechanisms of FGF23 Pathophysiology
    Hanudel, Mark R.
    Laster, Marciana
    Salusky, Isidro B.
    [J]. CURRENT OSTEOPOROSIS REPORTS, 2018, 16 (06): : 724 - 729
  • [2] A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis
    Insogna, Karl L.
    Briot, Karine
    Imel, Erik A.
    Kamenicky, Peter
    Ruppe, Mary D.
    Portale, Anthony A.
    Weber, Thomas
    Pitukcheewanont, Pisit
    Cheong, Hae Il
    de Beur, Suzanne Jan
    Imanishi, Yasuo
    Ito, Nobuaki
    Lachmann, Robin H.
    Tanaka, Hiroyuki
    Perwad, Farzana
    Zhang, Lin
    Chen, Chao-Yin
    Theodore-Oklota, Christina
    Mealiffe, Matt
    Martin, Javier San
    Carpenter, Thomas O.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (08) : 1383 - 1393
  • [3] Klein Klara, 2018, BMJ Case Rep, V2018, DOI 10.1136/bcr-2017-222851
  • [4] Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia
    Schouten, Belinda J.
    Doogue, Matthew P.
    Soule, Steven G.
    Hunt, Penelope J.
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 2009, 46 : 167 - 169
  • [5] Hypophosphatemia induced by intravenous administration of saccharated ferric oxide Another form of FGF23-related hypophosphatemia
    Shimizu, Yuichiro
    Tada, Yuko
    Yamauchi, Mika
    Okamoto, Takaaki
    Suzuki, Hisanori
    Ito, Nobuaki
    Fukumoto, Seiji
    Sugimoto, Toshitsugu
    Fujita, Toshiro
    [J]. BONE, 2009, 45 (04) : 814 - 816
  • [6] Randomized trial of intravenous iron-induced hypophosphatemia
    Wolf, Myles
    Chertow, Glenn M.
    Macdougall, Lain C.
    Kaper, Robert
    Krop, Julie
    Strauss, William
    [J]. JCI INSIGHT, 2018, 3 (23):
  • [7] Fibroblast Growth Factor 23-Related Osteomalacia Caused by the Prolonged Administration of Saccharated Ferric Oxide
    Yamamoto, Sunao
    Okada, Yosuke
    Mori, Hiroko
    Fukumoto, Seiji
    Tanaka, Yoshiya
    [J]. INTERNAL MEDICINE, 2012, 51 (17) : 2375 - 2378